Assessing the Variations in Breast/Ovarian Cancer Risk for Chinese BRCA1/2 Carriers.
Ang LiShuai HaoJiaqi LuoYi ZiZhaoji LanTianliangwen ZhouQihuan ZhiJiamin ZhanGang SunYujian ShiDonglin LuoPublished in: Journal of oncology (2022)
carriers with different genotypes have significantly different cancer risks. An optimal risk assessment should be mutation specific, rather than concerning a single figure.